Global Bioresorbable Scaffold Market (Sales, Revenue, Price, Gross Profit and Competitors Analysis of Major Market) from 2016-2027
- Published Date: 2021-04-23
- Report ID: 104640
- Pages: 114
-
Format:
Summary
As the world continues to deal with COVID-19, economies are moving into recession, under multiple adverse factors, the GDP of European and American countries in the second quarter suffered a historical contraction. At an annualized rate, the US GDP fell by 32.9% month on month, while the overall GDP of the euro zone fell by 12.1%.
Moreover, the economic prospects of Europe and the United States in the third quarter under the epidemic situation are hardly optimistic. The resumption of work and production not only brought economic data back, but also triggered a rebound in the epidemic situation. At present, the United States is still the 'epicenter' of the global epidemic. The total number of confirmed cases has exceeded 4.8 million, and the epidemic situation in some European countries has also rebounded. Affected by this, more than 20 states in the United States have announced the suspension or withdrawal of part of the economic restart plan. Britain and Italy have also decided to extend the state of emergency. The rebound of the epidemic situation has posed considerable risks to the economic prospects of Europe and the United States.
In the second quarter of this year, US GDP shrank by 9.5% on a month on month basis, or 32.9% at an annual rate, the largest decline since the 1940s. Data show that the sharp decline in personal consumption is the main drag on the U.S. GDP growth in the second quarter.
Compared with the United States, Europe's economic contraction in the second quarter was smaller, but it was also the lowest on record, with Germany and France contracting more than 10%. According to the data released by the Federal Bureau of statistics, Germany's GDP fell by 10.1% in the second quarter after adjusting for prices, seasons and working days, the largest decline since the quarterly economic data were available in 1970.
Thanks to the effective control and policy support of the new epidemic, China's economy rebounded sharply in the second quarter. The growth rate of manufacturing industry, which accounted for about 28% of GDP, rebounded sharply to 4.4% from the negative value in the first quarter. Chinese original equipment manufacturers (OEMs) and suppliers are ramping up production. And there are increased investments in digital footprints in manufacturing. OEMs in other parts of the world are offering incentives to drive sales. Prudent Markets published a report for global Bioresorbable Scaffold market in this environment.
In terms of revenue, this research report indicated that the global Bioresorbable Scaffold market was valued at USD XXX million in 2020, and it is expected to reach a value of USD XXX million by 2027, at a CAGR of XX % over the forecast period 2021-2027. Correspondingly, the forecast analysis of Bioresorbable Scaffold industry comprises of China, USA, Japan, India, Korea and South America, with the production and revenue data in each of the sub-segments.
The Abbott Laboratories (U.S.) aims at producing XX K Units Bioresorbable Scaffold in 2020, with XX % production to take place in global market, Biotronik (Germany) accounts for a volume share of XX %.
Regional Segmentation (Value; Revenue, USD Million, 2026-2027) of Bioresorbable Scaffold Market by Prudent Markets Include
China
EU
USA
Japan
India
Southeast Asia
South America
Competitive Analysis; Who are the Major Players in Bioresorbable Scaffold Market
Abbott Laboratories (U.S.)
Biotronik (Germany)
REVA Medical, Inc. (U.S.)
Elixir Medical Corporation (U.S.)
Kyoto Medical Planning Co., Ltd. (Japan)
Amaranth Medical, Inc.
Arterial Remodeling Technologies
Meril Life Sciences Pvt. Ltd.
Arterius Limited
LEPU MEDICAL TECHNOLOGY CO., LTD.
Boston Scientific Corporation
480 Biomedical
S3V Vascular Technologies Private Limited
Qualimed (Part of Q3 Medical Group)
ORBUSNEICH
...
Major Type of Bioresorbable Scaffold Covered in Prudent Markets report:
Degradable Polymer Materials
Degradable Inorganic Materials
Composite Materials
Application Segments Covered in Prudent Markets Market
Hospitals
Cardiac Centers
Application 3
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Bioresorbable Scaffold Market Analysis 2021, With Top Companies, Production, Revenue, Consumption, Price and Growth Rate
1 Market Scope
1.1 Product Details and Introduction
1.1.1 Degradable Polymer Materials -Product Introduction and Major Manufacturers
1.1.2 Degradable Inorganic Materials -Product Introduction and Major Manufacturers
1.1.3 Composite Materials -Product Introduction and Major Manufacturers
1.2 Market Snapshot
1.2.1 Major Companies Overview
1.2.2 Market Concentration
1.2.3 Six-Year Compound Annual Growth Rate (CAGR)
2 Global Bioresorbable Scaffold Market Assessment, by Segmentation
2.1 Type Breakdown Estimates & Forecast, Sales Volume (2026-2027)
2.2 Type Breakdown Estimates & Forecast, Sales Value (2026-2027)
2.3 Application Breakdown Estimates & Forecast, by Application (2026-2027)
3 Regional Market Analysis
3.1 China Bioresorbable Scaffold Market
3.1.1 Top Companies leading Bioresorbable Scaffold Development in China (2016-2021)
3.1.2 Sales Value of Major Company in China Market (2016-2021)
3.1.3 China Bioresorbable Scaffold Price (USD/Unit), by Type (2019-2020)
3.1.4 Sales in China Market, by Type (2026-2027)
3.2 EU Bioresorbable Scaffold Market
3.2.1 Top Companies leading Bioresorbable Scaffold Development in EU (2016-2021)
3.2.2 Sales Value of Major Company in EU Market (2016-2021)
3.2.3 EU Bioresorbable Scaffold Price (USD/Unit), by Type (2019-2020)
3.2.4 Sales in EU Market, by Type (2026-2027)
3.3 USA Bioresorbable Scaffold Market
3.3.1 Top Companies leading Bioresorbable Scaffold Development in USA (2016-2021)
3.3.2 Sales Value of Major Company in USA Market (2016-2021)
3.3.3 USA Bioresorbable Scaffold Price (USD/Unit), by Type (2019-2020)
3.3.4 Sales in USA Market, by Type (2026-2027)
3.4 Japan Bioresorbable Scaffold Market
3.4.1 Top Companies leading Bioresorbable Scaffold Development in Japan (2016-2021)
3.4.2 Sales Value of Major Company in Japan Market (2016-2021)
3.4.3 Japan Bioresorbable Scaffold Price (USD/Unit), by Type (2019-2020)
3.4.4 Sales in Japan Market, by Type (2026-2027)
3.5 India Bioresorbable Scaffold Market
3.5.1 Top Companies leading Bioresorbable Scaffold Development in India (2016-2021)
3.5.2 Sales Value of Major Company in India Market (2016-2021)
3.5.3 India Bioresorbable Scaffold Price (USD/Unit), by Type (2019-2020)
3.5.4 Sales in India Market, by Type (2026-2027)
3.6 Southeast Asia Bioresorbable Scaffold Market
3.6.1 Top Companies leading Bioresorbable Scaffold Development in Southeast Asia (2016-2021)
3.6.2 Sales Value of Major Company in Southeast Asia Market (2016-2021)
3.6.3 Southeast Asia Bioresorbable Scaffold Price (USD/Unit), by Type (2019-2020)
3.6.4 Sales in Southeast Asia Market, by Type (2026-2027)
3.7 South America Bioresorbable Scaffold Market
3.7.1 Top Companies leading Bioresorbable Scaffold Development in South America (2016-2021)
3.7.2 Sales Value of Major Company in South America Market (2016-2021)
3.7.3 South America Bioresorbable Scaffold Price (USD/Unit), by Type (2019-2020)
3.7.4 Sales in South America Market, by Type (2026-2027)
4 Value Chain (Impact of COVID-19)
4.1 Bioresorbable Scaffold Value Chain Analysis
4.1.1 Upstream
4.1.2 Downstream
4.2 COVID-19 Impact on Bioresorbable Scaffold Industry
4.2.1 Industrial Policy Issued Under the Epidemic Situation
4.3 Cost-Under the Epidemic Situation
4.3.1 Cost of Raw Material
4.4 Channel Analysis
4.4.1 Distribution Channel-Under the Epidemic Situation
4.4.2 Distributors
5 Regional Market Forecast (2021-2027)
5.1 Global Bioresorbable Scaffold Sales and Growth Rate (2021-2027)
5.2 Global Bioresorbable Scaffold Sales Value and Growth Rate (2021-2027)
6 Bioresorbable Scaffold Competitive Analysis
6.1 Abbott Laboratories (U.S.)
6.1.1 Abbott Laboratories (U.S.) Company Profiles
6.1.2 Abbott Laboratories (U.S.) Product Introduction
6.1.3 Abbott Laboratories (U.S.) Bioresorbable Scaffold Production, Revenue (2016-2021)
6.1.4 SWOT Analysis
6.2 Biotronik (Germany)
6.2.1 Biotronik (Germany) Company Profiles
6.2.2 Biotronik (Germany) Product Introduction
6.2.3 Biotronik (Germany) Bioresorbable Scaffold Production, Revenue (2016-2021)
6.2.4 SWOT Analysis
6.3 REVA Medical, Inc. (U.S.)
6.3.1 REVA Medical, Inc. (U.S.) Company Profiles
6.3.2 REVA Medical, Inc. (U.S.) Product Introduction
6.3.3 REVA Medical, Inc. (U.S.) Bioresorbable Scaffold Production, Revenue (2016-2021)
6.3.4 SWOT Analysis
6.4 Elixir Medical Corporation (U.S.)
6.4.1 Elixir Medical Corporation (U.S.) Company Profiles
6.4.2 Elixir Medical Corporation (U.S.) Product Introduction
6.4.3 Elixir Medical Corporation (U.S.) Bioresorbable Scaffold Production, Revenue (2016-2021)
6.4.4 SWOT Analysis
6.5 Kyoto Medical Planning Co., Ltd. (Japan)
6.5.1 Kyoto Medical Planning Co., Ltd. (Japan) Company Profiles
6.5.2 Kyoto Medical Planning Co., Ltd. (Japan) Product Introduction
6.5.3 Kyoto Medical Planning Co., Ltd. (Japan) Bioresorbable Scaffold Production, Revenue (2016-2021)
6.5.4 SWOT Analysis
6.6 Amaranth Medical, Inc.
6.6.1 Amaranth Medical, Inc. Company Profiles
6.6.2 Amaranth Medical, Inc. Product Introduction
6.6.3 Amaranth Medical, Inc. Bioresorbable Scaffold Production, Revenue (2016-2021)
6.6.4 SWOT Analysis
6.7 Arterial Remodeling Technologies
6.7.1 Arterial Remodeling Technologies Company Profiles
6.7.2 Arterial Remodeling Technologies Product Introduction
6.7.3 Arterial Remodeling Technologies Bioresorbable Scaffold Production, Revenue (2016-2021)
6.7.4 SWOT Analysis
6.8 Meril Life Sciences Pvt. Ltd.
6.8.1 Meril Life Sciences Pvt. Ltd. Company Profiles
6.8.2 Meril Life Sciences Pvt. Ltd. Product Introduction
6.8.3 Meril Life Sciences Pvt. Ltd. Bioresorbable Scaffold Production, Revenue (2016-2021)
6.8.4 SWOT Analysis
6.9 Arterius Limited
6.9.1 Arterius Limited Company Profiles
6.9.2 Arterius Limited Product Introduction
6.9.3 Arterius Limited Bioresorbable Scaffold Production, Revenue (2016-2021)
6.9.4 SWOT Analysis
6.10 LEPU MEDICAL TECHNOLOGY CO., LTD.
6.10.1 LEPU MEDICAL TECHNOLOGY CO., LTD. Company Profiles
6.10.2 LEPU MEDICAL TECHNOLOGY CO., LTD. Product Introduction
6.10.3 LEPU MEDICAL TECHNOLOGY CO., LTD. Bioresorbable Scaffold Production, Revenue (2016-2021)
6.10.4 SWOT Analysis
6.11 Boston Scientific Corporation
6.12 480 Biomedical
6.13 S3V Vascular Technologies Private Limited
6.14 Qualimed (Part of Q3 Medical Group)
6.15 ORBUSNEICH
7 Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
